
Please try another search
IMCD NV's Q2 2025 earnings call revealed a mixed financial performance for the $6.8 billion market cap company, leading to a notable stock price decline in pre-market trading. Despite a 6% increase in...
Investing.com -- IMCD N.V. (AS:IMCD) shares fell over 9% on Wednesday after it reported second-quarter EBITA of €133.2 million, a 7% decrease and 6% below consensus estimates of €141.7 million, as...
Introduction & Market Context IMCD NV ( AMS (VIE:AMS2):AS:IMCD), a leading global distributor of specialty chemicals and ingredients, presented its half-year 2025 results on July 30, 2025. The...
Investing.com -- UBS has upgraded IMCD NV (AS:IMCD) to “neutral” from “sell,” citing that the company's valuation now adequately reflects near-term earnings pressures, in a note dated...
Investing.com - UBS upgraded IMCD NV (AS:IMCD) to Neutral from Sell on Monday, while slightly lowering its price target to EUR122.00 from EUR128.00. The upgrade comes as IMCD shares have fallen...
Investing.com - Deutsche Bank (ETR:DBKGn) upgraded IMCD NV (AS:IMCD) from Hold to Buy and raised its price target to EUR136.00 from EUR126.00 on Wednesday. The upgrade reflects Deutsche Bank's...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review